These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20820815)

  • 21. Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.
    Ahn S; Lee YS; Chun YH; Kwon IH; Kim W; Lim KS; Kim TW; Lee KH
    Support Care Cancer; 2011 Aug; 19(8):1151-8. PubMed ID: 20552376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
    Klastersky J; Paesmans M; Rubenstein EB; Boyer M; Elting L; Feld R; Gallagher J; Herrstedt J; Rapoport B; Rolston K; Talcott J
    J Clin Oncol; 2000 Aug; 18(16):3038-51. PubMed ID: 10944139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.
    Bhardwaj PV; Emmich M; Knee A; Ali F; Walia R; Roychowdhury P; Clark J; Sridhar A; Lagu T; Loh KP
    Support Care Cancer; 2021 Oct; 29(10):5905-5914. PubMed ID: 33761002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
    Ono Y; Hayama N; Hattori S; Ito Y; Oguma T; Sakamaki F; Asano K
    Thorac Cancer; 2022 Dec; 13(24):3504-3509. PubMed ID: 36330990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.
    Choi A; Park I; Lee HS; Chung J; Kim MJ; Park YS
    Ann Med; 2022 Dec; 54(1):599-609. PubMed ID: 35175159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality.
    Sütcüoğlu O; Akdoğan O; İnci BK; Gürler F; Özdemir N; Yazıcı O
    Support Care Cancer; 2021 Feb; 29(2):1047-1053. PubMed ID: 32583058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study.
    Li Z; Wu X; Gao X; Shan F; Ying X; Zhang Y; Ji J
    Cancer Med; 2020 Sep; 9(17):6205-6215. PubMed ID: 32666682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of the MASCC scale in the management of neutropenic fever induced by chemotherapy in patients with solid neoplasm].
    Gayol Mdel C; Font A; Casas I; Estrada O; Domínguez MJ; Pedro-Botet ML
    Med Clin (Barc); 2009 Sep; 133(8):296-9. PubMed ID: 19376542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study.
    Bozcuk H; Yıldız M; Artaç M; Kocer M; Kaya Ç; Ulukal E; Ay S; Kılıç MP; Şimşek EH; Kılıçkaya P; Uçar S; Coskun HS; Savas B
    Support Care Cancer; 2015 Jun; 23(6):1759-67. PubMed ID: 25433439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?
    Moon H; Choi YJ; Sim SH
    PLoS One; 2018; 13(12):e0210019. PubMed ID: 30596803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
    Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
    Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.
    Nguyen M; Jacobson T; Torres J; Wann A
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1345. PubMed ID: 33635593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for poor prognosis febrile neutropenia.
    Ahn S; Lee YS
    Curr Opin Oncol; 2012 Jul; 24(4):376-80. PubMed ID: 22476191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia.
    Gunderson CC; Erickson BK; Wilkinson-Ryan I; Vesely SK; Leath CA; Gehrig PA; Moore KN
    Am J Clin Oncol; 2019 Feb; 42(2):138-142. PubMed ID: 30557164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent factors for prediction of poor outcomes in patients with febrile neutropenia.
    Günalp M; Koyunoğlu M; Gürler S; Koca A; Yeşilkaya I; Öner E; Akkaş M; Metin Aksu N; Demirkan A; Polat O; Elhan AH
    Med Sci Monit; 2014 Oct; 20():1826-32. PubMed ID: 25282155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H; Johansson E; Björkholm M; Kalin M
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review.
    Pherwani N; Ghayad JM; Holle LM; Karpiuk EL
    Am J Health Syst Pharm; 2015 Apr; 72(8):619-31. PubMed ID: 25825185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial neural networks improve LDCT lung cancer screening: a comparative validation study.
    Hsu YC; Tsai YH; Weng HH; Hsu LS; Tsai YH; Lin YC; Hung MS; Fang YH; Chen CW
    BMC Cancer; 2020 Oct; 20(1):1023. PubMed ID: 33092589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
    Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
    J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.